Health-Care Deals in May Relatively Strong Despite Pandemic

Economic uncertainty caused by the pandemic continues to impede investors’ interest in health-care deals.

But transaction activity is comparably strong given overall market conditions, analysts say.

The 104 transactions in May represent the lowest number of deals announced or closed in any month this year, down from 106 in April. Still, the 686 deals year-to-date are “well ahead” of the 456 deals during the same period last year, Larry Kocot, a principal at KPMG LLP and a national leader of the firm’s Center for Healthcare Regulatory Insight, said.

Deal volume in the pharmaceutical sector continues at a steady rate as ...